Symbols

XCUR

Exicure·NASDAQ

--(--)

XCUR Profile

Exicure, Inc.

An early-stage biotechnology company that developing nucleic acid therapies targeting RNA to address neurological disorders and hair loss disorders

Industry

Pharmaceutical

Established Date

07/09/2015

Listing Date

07/31/2019

Exchange

NASDAQ Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.exicuretx.com

Security Type

Common stock

Office address

400 Seaport Court Suite 102 Redwood City CA 94063

Business

Introduction

Exicure, Inc., was founded on July 9, 2015. The company is focusing on exploring strategic alternatives after suspending its historical biotechnology R&D activities. It has acquired GPCR Therapeutics USA, which completed a Phase 2 clinical trial in blood cancer patients, and the company is managing related licensing and development obligations.